Samsung heir dodges jail over controversial merger

  • 📰 fmtoday
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 72%

South Africa News News

South Africa South Africa Latest News,South Africa South Africa Headlines

Lee Jae-yong has effectively been at the helm since his father suffered a heart attack in 2014. FMTNews

SEOUL: A South Korean court on Tuesday declined to issue an arrest warrant for the heir to South Korea’s Samsung empire over a controversial merger of two business units seen as a key step to his succession, Yonhap news agency reported.

Prosecutors had sought the arrest warrant for Lee on suspicion he was involved in price manipulation and illegal trading during the 2015 merger of Cheil Industries and Samsung C&T. “There was insufficient explanation on the need to arrest the defendants against the principle of trial without detention,” Judge Won Jung-sook said, according to Yonhap.

Chaebol families often have only a small ownership stake in their empires, but maintain control through complex webs of cross-shareholdings between units.Lee was the largest shareholder in Cheil Industries, and critics say Samsung sought to artificially lower the price of C&T to give him a bigger stake in the merged entity – a key part of the Samsung structure – consolidating his grip on the conglomerate.

Lee, 51, has effectively been at the helm of Samsung – South Korea’s biggest business group – since his father and Samsung group boss Lee Kun-hee suffered a heart attack in 2014.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 5. in ZA

South Africa South Africa Latest News, South Africa South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Report: Astra eyes record merger with drug rival Gilead | Malay MailLONDON, June 8 — British pharmaceuticals group AstraZeneca has approached US rival Gilead Sciences over a possible record merger, Bloomberg reported, as the pair spearhead treatments for Covid-19. AstraZeneca informally contacted Gilead last month, yesterday’s report said, adding that a...
Source: malaymail - 🏆 1. / 86 Read more »